Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the US Food and Drug Administration and the US Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the US should be lifted and use of the vaccine should resume.
